作者
Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, Rhea Harewood, Melissa Matz, Maja Nikšić, Audrey Bonaventure, Mikhail Valkov, Christopher J Johnson, Jacques Estève, Olufemi J Ogunbiyi, Gulnar Azevedo e Silva, Wan-Qing Chen, Sultan Eser, Gerda Engholm, Charles A Stiller, Alain Monnereau, Ryan R Woods, Otto Visser, Gek Hsiang Lim, Joanne Aitken, Hannah K Weir, Michel P Coleman, S Bouzbid, M Hamdi-Chérif, Z Zaidi, K Meguenni, D Regagba, S Bayo, T Cheick Bougadari, SS Manraj, K Bendahhou, A Fabowale, D Bradshaw, NIM Somdyala, I Kumcher, F Moreno, GH Calabrano, SB Espinola, B Carballo Quintero, R Fita, MC Diumenjo, WD Laspada, SG Ibañez, CA Lima, PCF De Souza, K Del Pino, C Laporte, MP Curado, JC de Oliveira, CLA Veneziano, DB Veneziano, MRDO Latorre, LF Tanaka, MS Rebelo, MO Santos, JC Galaz, M Aparicio Aravena, J Sanhueza Monsalve, DA Herrmann, S Vargas, VM Herrera, CJ Uribe, LE Bravo, LS Garcia, NE Arias-Ortiz, D Morantes, DM Jurado, MC Yépez Chamorro, S Delgado, M Ramirez, YH Galán Alvarez, P Torres, F Martínez-Reyes, L Jaramillo, R Quinto, J Castillo, M Mendoza, P Cueva, JG Yépez, B Bhakkan, J Deloumeaux, C Joachim, J Macni, R Carrillo, J Shalkow Klincovstein, R Rivera Gomez, E Poquioma, G Tortolero-Luna, D Zavala, R Alonso, E Barrios, A Eckstrand, C Nikiforuk, G Noonan, D Turner, E Kumar, B Zhang, FR McCrate, S Ryan, M MacIntyre, N Saint-Jacques, DE Nishri, CA McClure, KA Vriends, S Kozie, H Stuart-Panko, T Freeman, JT George, JT Brockhouse, DK O'Brien, A Holt, L Almon, S Kwong, C Morris, R Rycroft, L Mueller, CE Phillips, H Brown, B Cromartie, AG Schwartz, F Vigneau, GM Levin, B Wohler, R Bayakly, KC Ward, SL Gomez, M McKinley, R Cress, MD Green, K Miyagi, LP Ruppert, CF Lynch, B Huang, TC Tucker, D Deapen, L Liu, MC Hsieh, XC Wu, M Schwenn, ST Gershman, RC Knowlton, G Alverson, GE Copeland, S Bushhouse, DB Rogers, J Jackson-Thompson, D Lemons, HJ Zimmerman, M Hood
发表日期
2018/3/17
期刊
The Lancet
卷号
391
期号
10125
页码范围
1023-1075
出版商
Elsevier
简介
Background
In 2015, the second cycle of the CONCORD programme established global surveillance of cancer survival as a metric of the effectiveness of health systems and to inform global policy on cancer control. CONCORD-3 updates the worldwide surveillance of cancer survival to 2014.
Methods
CONCORD-3 includes individual records for 37·5 million patients diagnosed with cancer during the 15-year period 2000–14. Data were provided by 322 population-based cancer registries in 71 countries and territories, 47 of which provided data with 100% population coverage. The study includes 18 cancers or groups of cancers: oesophagus, stomach, colon, rectum, liver, pancreas, lung, breast (women), cervix, ovary, prostate, and melanoma of the skin in adults, and brain tumours, leukaemias, and lymphomas in both adults and children. Standardised quality control procedures were applied; errors were rectified by …
学术搜索中的文章
C Allemani, T Matsuda, V Di Carlo, R Harewood… - The Lancet, 2018
C Allemani, T Matsuda, V Di Carlo, R Harewood… - Physiol Behav, 2019